Junji Kobayashi

4.8k citations

158 papers · 3.7k indexed · h-index 35

Endocrinology, Diabetes and Metabolism top 0.5%
Surgery top 2%
Cardiology and Cardiovascular Medicine top 1%
Molecular Biology top 10%
Epidemiology top 5%

Co-authors: Hiroshi Mabuchi Atsushi Nohara Akihiro Inazu Masa‐aki Kawashiri Masakazu Yamagishi Junji Koizumi Katsuyuki Nakajima Hideaki Bujo
Topics: Diabetes, Cardiovascular Risks, and Lipoproteins (70 papers)Lipoproteins and Cardiovascular Health (54 papers)Lipid metabolism and disorders (46 papers)
Cited by: Endocrinology, Diabetes and Metabolism Cardiology and Cardiovascular Medicine Surgery
Journals: Journal of Biological Chemistry Circulation Journal of Clinical Investigation
Partner nations: Japan United States Australia

In The Last Decade

Junji Kobayashi

153 papers receiving 3.6k citations

Peers

Countries citing papers authored by Junji Kobayashi

Since Specialization

Citations

This map shows the geographic impact of Junji Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Kobayashi more than expected).

Fields of papers citing papers by Junji Kobayashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junji Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Kobayashi. The network helps show where Junji Kobayashi may publish in the future.

Co-authorship network of co-authors of Junji Kobayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Junji Kobayashi. A scholar is included among the top collaborators of Junji Kobayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junji Kobayashi. Junji Kobayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Familial hypercholesterolemia with special focus on Japan 2024 ·Clinica Chimica Acta ·Junji Kobayashi,(unknown),Hayato Tada,Koutaro Yokote	0
2	An automated method for measuring lipoprotein lipase and hepatic triglyceride lipase activities in post-heparin plasma 2018 ·Clinica Chimica Acta ·Kiyomi Nakajima,(unknown),Tetsuo Machida,Shigeyuki Imamura,(unknown),Kazuya Miyashita,Isamu Fukamachi,Masahiro Maeda,(unknown),Takafumi Koga,Junji Kobayashi,Takao Kimura,Katsuyuki Nakajima,Masami Murakami	7
3	Induction Murine Models of Chronic Fatigue Syndrome byBrucella abortusAntigen Injections: Is Anemia Induced or Not? 2015 ·BioMed Research International ·Junji Moriya,(unknown),(unknown),(unknown),Jun-ichi Yamakawa,Junji Kobayashi,Yasuhito Ishigaki	3
4	Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation 2014 ·Atherosclerosis ·Hiroshi Mabuchi,Atsushi Nohara,Tohru Noguchi,Junji Kobayashi,Masa‐aki Kawashiri,Takeshi Inoue,Mika Mori,Hayato Tada,Chiaki Nakanishi,Kunimasa Yagi,Masakazu Yamagishi,Kousei Ueda,Tadayoshi Takegoshi,Susumu Miyamoto,Akihiro Inazu,Junji Koizumi	64
5	Comparison of the effect of post-heparin and pre-heparin lipoprotein lipase and hepatic triglyceride lipase on remnant lipoprotein metabolism 2014 ·Clinica Chimica Acta ·Takashi Shirakawa,Katsuyuki Nakajima,Younosuke Shimomura,Junji Kobayashi,Kimber L. Stanhope,Peter J. Havel,Tetsuo Machida,Hiroyuki Sumino,Masami Murakami	23
6	Successful Treatment of Post-influenza Chronic Fatigue Syndrome with Kampo Medicine : a Case Report 2014 ·Kampo Medicine ·Junji Moriya,Kenji Takeuchi,(unknown),(unknown),Yoshiharu Motoo,Hideki Hashimoto,(unknown),Junji Kobayashi,Jun-ichi Yamakawa	1
7	Significance of Kampo, Traditional Japanese Medicine, in Supportive Care of Cancer Patients 2013 ·Evidence-based Complementary and Alternative Medicine ·Jun-ichi Yamakawa,Yoshiharu Motoo,Junji Moriya,Masao Ogawa,(unknown),(unknown),Toshiyuki Sasagawa,Matomo Nishio,Junji Kobayashi	16
8	Significance of Kampo, Japanese Traditional Medicine, in the Treatment of Obesity: Basic and Clinical Evidence 2013 ·Evidence-based Complementary and Alternative Medicine ·Jun-ichi Yamakawa,Junji Moriya,Kenji Takeuchi,(unknown),Yoshiharu Motoo,Junji Kobayashi	14
9	Impact of Serum Retinol-Binding Protein 4 Levels on Regulation of Remnant-Like Particles Triglyceride in Type 2 Diabetes Mellitus 2013 ·Journal of Diabetes Research ·(unknown),Kunimasa Yagi,Junji Kobayashi,Atsushi Nohara,Naoko Ito,Akimichi Asano,Kaoru Nakano,Jianhui Liu,(unknown),Yukiko Mori,(unknown),(unknown),Yoshiyu Takeda,Masakazu Yamagishi	8
10	Short-Term Effect of Pitavastatin Treatment on Glucose and Lipid Metabolism and Oxidative Stress in Fasting and Postprandial State Using a Test Meal in Japanese Men 2013 ·PubMed ·Hirokazu Kakuda,Junji Kobayashi,(unknown),Noboru Takekoshi	12
11	Novel mutations of cholesteryl ester transfer protein (CETP) gene in Japanese hyperalphalipoproteinemic subjects 2011 ·Clinica Chimica Acta ·(unknown),Akihiro Inazu,Yoshihiro Noji,Takanobu WAKASUGI,Kenji Miwa,Hayato Tada,Masa‐aki Kawashiri,Tohru Noguchi,Atsushi Nohara,Junji Kobayashi,Junji Koizumi,Masakazu Yamagishi,Hiroshi Mabuchi	12
12	Difference between Fasting and Nonfasting Triglyceridemia; the Influence of Waist Circumference 2009 ·Journal of Atherosclerosis and Thrombosis ·Rie Oka,Junji Kobayashi,Katsuyuki Miura,Shin‐ya Nagasawa,Tadashi Moriuchi,Senshu Hifumi,Susumu Miyamoto,Masa‐aki Kawashiri,Atsushi Nohara,Akihiro Inazu,Yoshiyu Takeda,Hiroshi Mabuchi,Kunimasa Yagi,Masakazu Yamagishi	16
13	Raloxifene promotes adipocyte differentiation of 3T3-L1 cells 2006 ·European Journal of Pharmacology ·Yuko Murase,Junji Kobayashi,Atsushi Nohara,Akimichi Asano,(unknown),Kaoru Suzuki,Hiroshi Sato,Hiroshi Mabuchi	23
14	A novel method for measuring human hepatic lipase activity in postheparin plasma 2006 ·Journal of Lipid Research ·Shigeyuki Imamura,Junji Kobayashi,Shin‐ichi Sakasegawa,Atsushi Nohara,Katsuyuki Nakajima,Masa‐aki Kawashiri,Akihiro Inazu,Masakazu Yamagishi,Jun‐ichi Koizumi,Hiroshi Mabuchi	9
15	Reduction of Serum Ubiquinol-10 and Ubiquinone-10 Levels by Atorvastatin in Hypercholesterolemic Patients 2005 ·Journal of Atherosclerosis and Thrombosis ·Hiroshi Mabuchi,Toshinori Higashikata,Masa‐aki Kawashiri,Shoji Katsuda,Mihoko Mizuno,Atsushi Nohara,Akihiro Inazu,Junji Koizumi,Junji Kobayashi	97
16	Marked decrease in plasma apolipoprotein A-I and high density lipoprotein-cholesterol in a case with Werner syndrome 2000 ·Clinica Chimica Acta ·Junji Kobayashi,Shunichi Murano,Koutaro Yokote,Seijiro Mori,Akira Matsunaga,Junichi Sasaki,Kazuo Takahashi,Hideaki Bujo,Yasushi Saitō	5
17	A Naturally Occurring Mutation at the Second Base of Codon Asparagine 43 in the Proposed N-Linked Glycosylation Site of Human Lipoprotein Lipase: In Vivo Evidence That Asparagine 43 Is Essential for Catalysis and Secretion 1994 ·Biochemical and Biophysical Research Communications ·Junji Kobayashi,Hidekuni Inadera,Yuki Fujita,Glenda D. Talley,Naoko Morisaki,Sayaka Yoshida,Y Saito,S S Fojo,H. Bryan Brewer	11
18	A Missense Mutation (Trp26→Arg) in Exon 3 of the Apolipoprotein CII Gene in a Patient with Apolipoprotein CII Deficiency (Apo CII-Wakayama) 1993 ·Biochemical and Biophysical Research Communications ·Hidekuni Inadera,(unknown),Junji Kobayashi,Tamotsu Kanzaki,(unknown),(unknown),Yusuke Saito,Shigeo Yoshida	20
19	Lipoprotein lipase mass and activity in severe hypertriglyceridemia 1993 ·Clinica Chimica Acta ·Junji Kobayashi,Hideyuki Hashimoto,Isamu Fukamachi,Jun Tashiro,(unknown),Yasushi Saito,(unknown)	115
20	Familial chylomicronemia (type I hyperlipoproteinemia) due to a single missense mutation in the lipoprotein lipase gene. 1991 ·Journal of Clinical Investigation ·Detlev Ameis,Junji Kobayashi,R.C. Davis,Osnat Ben-Zeev,(unknown),John P. Kane,(unknown),Hubert Wong,(unknown),Michael C. Schotz	55

About Junji Kobayashi

Junji Kobayashi is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery, having authored 158 papers that have together received 3.7k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (70 papers), Lipoproteins and Cardiovascular Health (54 papers) and Lipid metabolism and disorders (46 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.6k citations), Cardiology and Cardiovascular Medicine (1.3k citations) and Surgery (1.4k citations). Junji Kobayashi has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Hiroshi Mabuchi, Atsushi Nohara, Akihiro Inazu, Masa‐aki Kawashiri, Masakazu Yamagishi, Junji Koizumi, Katsuyuki Nakajima, Hideaki Bujo, Hayato Tada and Shoji Katsuda. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact